- Prevention of pulmonary vascular remodeling and of decreased BMPR-2 expression by losartan therapy in shunt-induced pulmonary hypertension. Rondelet, B., Kerbaul, F., Van Beneden, R., Hubloue, I., Huez, S., Fesler, P., Remmelink, M., Brimioulle, S., Salmon, I., Naeije, R. Am. J. Physiol. Heart Circ. Physiol. (2005)